AI assistant
Sending…
RESMED INC — Director's Dealing 2010
May 13, 2010
30071_dirs_2010-05-13_36f2b219-3a7a-4cc9-82ac-ecc5ff760443.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-05-11
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-11 | ResMed Common Stock | M | 5000 | $40.80 | Acquired | 13435.439 | Direct |
| 2010-05-11 | ResMed Common Stock | S | 5000 | $66.00 | Disposed | 8435.439 | Direct |
| 2010-05-11 | ResMed Common Stock | M | 7500 | $47.75 | Acquired | 15935.439 | Direct |
| 2010-05-11 | ResMed Common Stock | S | 7500 | $66.00 | Disposed | 8435.439 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-11 | ResMed Common Stock Options | $40.80 | M | 5000 | Disposed | 2015-12-01 | ResMed Common Stock (5000) | Direct |
| 2010-05-11 | ResMed Common Stock Options | $47.75 | M | 7500 | Disposed | 2016-07-07 | ResMed Common Stock (7500) | Direct |
Footnotes
F1: Represents first date options became exercisable.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29